0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemodialyzer and Hemoperfusion Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-33R13922
Home | Market Reports | Health| Medical Devices & Equipment
Global Hemodialyzer and Hemoperfusion Market Research Report 2023
BUY CHAPTERS

Global Hemodialyzer and Hemoperfusion Market Research Report 2025

Code: QYRE-Auto-33R13922
Report
May 2025
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemodialyzer and Hemoperfusion Market Size

The global market for Hemodialyzer and Hemoperfusion was valued at US$ 1441 million in the year 2024 and is projected to reach a revised size of US$ 2299 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Hemodialyzer and Hemoperfusion Market

Hemodialyzer and Hemoperfusion Market

Blood purification is a treatment in which a patient"s blood is passed through a device in which solute (waste products, toxins) and possibly water is removed. With these advances, blood purification as a treatment for human septic shock was born.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hemodialyzer and Hemoperfusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemodialyzer and Hemoperfusion.
The Hemodialyzer and Hemoperfusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hemodialyzer and Hemoperfusion market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemodialyzer and Hemoperfusion manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hemodialyzer and Hemoperfusion Market Report

Report Metric Details
Report Name Hemodialyzer and Hemoperfusion Market
Accounted market size in year US$ 1441 million
Forecasted market size in 2031 US$ 2299 million
CAGR 7.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Hemodialyzer
  • Hemoperfusion
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Fresenius Medical Care, Baxter, Nipro, Asahi Kasei, Toray, B.Braun, Nikkiso, SB-KAWASUM, Medica Group, WEGO Group, Lengthen, Shanghai Peony Medical, Chengdu OCI Medical, Bain Medical Equipment, Jafron Biomedical, Kaneka Medix Corporation, CytoSorbents
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hemodialyzer and Hemoperfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hemodialyzer and Hemoperfusion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Hemodialyzer and Hemoperfusion Market growing?

Ans: The Hemodialyzer and Hemoperfusion Market witnessing a CAGR of 7.0% during the forecast period 2025-2031.

What is the Hemodialyzer and Hemoperfusion Market size in 2031?

Ans: The Hemodialyzer and Hemoperfusion Market size in 2031 will be US$ 2299 million.

Who are the main players in the Hemodialyzer and Hemoperfusion Market report?

Ans: The main players in the Hemodialyzer and Hemoperfusion Market are Fresenius Medical Care, Baxter, Nipro, Asahi Kasei, Toray, B.Braun, Nikkiso, SB-KAWASUM, Medica Group, WEGO Group, Lengthen, Shanghai Peony Medical, Chengdu OCI Medical, Bain Medical Equipment, Jafron Biomedical, Kaneka Medix Corporation, CytoSorbents

What are the Application segmentation covered in the Hemodialyzer and Hemoperfusion Market report?

Ans: The Applications covered in the Hemodialyzer and Hemoperfusion Market report are Dialysis Centers, Hospitals, Other

What are the Type segmentation covered in the Hemodialyzer and Hemoperfusion Market report?

Ans: The Types covered in the Hemodialyzer and Hemoperfusion Market report are Hemodialyzer, Hemoperfusion

Recommended Reports

Hemodialysis Equipment

Hemodialyzer Components

Blood Purification Solutions

1 Hemodialyzer and Hemoperfusion Market Overview
1.1 Product Definition
1.2 Hemodialyzer and Hemoperfusion by Type
1.2.1 Global Hemodialyzer and Hemoperfusion Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hemodialyzer
1.2.3 Hemoperfusion
1.3 Hemodialyzer and Hemoperfusion by Application
1.3.1 Global Hemodialyzer and Hemoperfusion Market Value by Application (2024 VS 2031)
1.3.2 Dialysis Centers
1.3.3 Hospitals
1.3.4 Other
1.4 Global Hemodialyzer and Hemoperfusion Market Size Estimates and Forecasts
1.4.1 Global Hemodialyzer and Hemoperfusion Revenue 2020-2031
1.4.2 Global Hemodialyzer and Hemoperfusion Sales 2020-2031
1.4.3 Global Hemodialyzer and Hemoperfusion Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hemodialyzer and Hemoperfusion Market Competition by Manufacturers
2.1 Global Hemodialyzer and Hemoperfusion Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hemodialyzer and Hemoperfusion Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hemodialyzer and Hemoperfusion Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hemodialyzer and Hemoperfusion, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemodialyzer and Hemoperfusion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemodialyzer and Hemoperfusion, Product Type & Application
2.7 Global Key Manufacturers of Hemodialyzer and Hemoperfusion, Date of Enter into This Industry
2.8 Global Hemodialyzer and Hemoperfusion Market Competitive Situation and Trends
2.8.1 Global Hemodialyzer and Hemoperfusion Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hemodialyzer and Hemoperfusion Players Market Share by Revenue
2.8.3 Global Hemodialyzer and Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemodialyzer and Hemoperfusion Market Scenario by Region
3.1 Global Hemodialyzer and Hemoperfusion Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hemodialyzer and Hemoperfusion Sales by Region: 2020-2031
3.2.1 Global Hemodialyzer and Hemoperfusion Sales by Region: 2020-2025
3.2.2 Global Hemodialyzer and Hemoperfusion Sales by Region: 2026-2031
3.3 Global Hemodialyzer and Hemoperfusion Revenue by Region: 2020-2031
3.3.1 Global Hemodialyzer and Hemoperfusion Revenue by Region: 2020-2025
3.3.2 Global Hemodialyzer and Hemoperfusion Revenue by Region: 2026-2031
3.4 North America Hemodialyzer and Hemoperfusion Market Facts & Figures by Country
3.4.1 North America Hemodialyzer and Hemoperfusion Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hemodialyzer and Hemoperfusion Sales by Country (2020-2031)
3.4.3 North America Hemodialyzer and Hemoperfusion Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hemodialyzer and Hemoperfusion Market Facts & Figures by Country
3.5.1 Europe Hemodialyzer and Hemoperfusion Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hemodialyzer and Hemoperfusion Sales by Country (2020-2031)
3.5.3 Europe Hemodialyzer and Hemoperfusion Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemodialyzer and Hemoperfusion Market Facts & Figures by Region
3.6.1 Asia Pacific Hemodialyzer and Hemoperfusion Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hemodialyzer and Hemoperfusion Sales by Region (2020-2031)
3.6.3 Asia Pacific Hemodialyzer and Hemoperfusion Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hemodialyzer and Hemoperfusion Market Facts & Figures by Country
3.7.1 Latin America Hemodialyzer and Hemoperfusion Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hemodialyzer and Hemoperfusion Sales by Country (2020-2031)
3.7.3 Latin America Hemodialyzer and Hemoperfusion Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemodialyzer and Hemoperfusion Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemodialyzer and Hemoperfusion Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hemodialyzer and Hemoperfusion Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hemodialyzer and Hemoperfusion Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemodialyzer and Hemoperfusion Sales by Type (2020-2031)
4.1.1 Global Hemodialyzer and Hemoperfusion Sales by Type (2020-2025)
4.1.2 Global Hemodialyzer and Hemoperfusion Sales by Type (2026-2031)
4.1.3 Global Hemodialyzer and Hemoperfusion Sales Market Share by Type (2020-2031)
4.2 Global Hemodialyzer and Hemoperfusion Revenue by Type (2020-2031)
4.2.1 Global Hemodialyzer and Hemoperfusion Revenue by Type (2020-2025)
4.2.2 Global Hemodialyzer and Hemoperfusion Revenue by Type (2026-2031)
4.2.3 Global Hemodialyzer and Hemoperfusion Revenue Market Share by Type (2020-2031)
4.3 Global Hemodialyzer and Hemoperfusion Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hemodialyzer and Hemoperfusion Sales by Application (2020-2031)
5.1.1 Global Hemodialyzer and Hemoperfusion Sales by Application (2020-2025)
5.1.2 Global Hemodialyzer and Hemoperfusion Sales by Application (2026-2031)
5.1.3 Global Hemodialyzer and Hemoperfusion Sales Market Share by Application (2020-2031)
5.2 Global Hemodialyzer and Hemoperfusion Revenue by Application (2020-2031)
5.2.1 Global Hemodialyzer and Hemoperfusion Revenue by Application (2020-2025)
5.2.2 Global Hemodialyzer and Hemoperfusion Revenue by Application (2026-2031)
5.2.3 Global Hemodialyzer and Hemoperfusion Revenue Market Share by Application (2020-2031)
5.3 Global Hemodialyzer and Hemoperfusion Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Fresenius Medical Care
6.1.1 Fresenius Medical Care Company Information
6.1.2 Fresenius Medical Care Description and Business Overview
6.1.3 Fresenius Medical Care Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Fresenius Medical Care Hemodialyzer and Hemoperfusion Product Portfolio
6.1.5 Fresenius Medical Care Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Baxter Hemodialyzer and Hemoperfusion Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Nipro
6.3.1 Nipro Company Information
6.3.2 Nipro Description and Business Overview
6.3.3 Nipro Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nipro Hemodialyzer and Hemoperfusion Product Portfolio
6.3.5 Nipro Recent Developments/Updates
6.4 Asahi Kasei
6.4.1 Asahi Kasei Company Information
6.4.2 Asahi Kasei Description and Business Overview
6.4.3 Asahi Kasei Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Asahi Kasei Hemodialyzer and Hemoperfusion Product Portfolio
6.4.5 Asahi Kasei Recent Developments/Updates
6.5 Toray
6.5.1 Toray Company Information
6.5.2 Toray Description and Business Overview
6.5.3 Toray Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Toray Hemodialyzer and Hemoperfusion Product Portfolio
6.5.5 Toray Recent Developments/Updates
6.6 B.Braun
6.6.1 B.Braun Company Information
6.6.2 B.Braun Description and Business Overview
6.6.3 B.Braun Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.6.4 B.Braun Hemodialyzer and Hemoperfusion Product Portfolio
6.6.5 B.Braun Recent Developments/Updates
6.7 Nikkiso
6.7.1 Nikkiso Company Information
6.7.2 Nikkiso Description and Business Overview
6.7.3 Nikkiso Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nikkiso Hemodialyzer and Hemoperfusion Product Portfolio
6.7.5 Nikkiso Recent Developments/Updates
6.8 SB-KAWASUM
6.8.1 SB-KAWASUM Company Information
6.8.2 SB-KAWASUM Description and Business Overview
6.8.3 SB-KAWASUM Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.8.4 SB-KAWASUM Hemodialyzer and Hemoperfusion Product Portfolio
6.8.5 SB-KAWASUM Recent Developments/Updates
6.9 Medica Group
6.9.1 Medica Group Company Information
6.9.2 Medica Group Description and Business Overview
6.9.3 Medica Group Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Medica Group Hemodialyzer and Hemoperfusion Product Portfolio
6.9.5 Medica Group Recent Developments/Updates
6.10 WEGO Group
6.10.1 WEGO Group Company Information
6.10.2 WEGO Group Description and Business Overview
6.10.3 WEGO Group Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.10.4 WEGO Group Hemodialyzer and Hemoperfusion Product Portfolio
6.10.5 WEGO Group Recent Developments/Updates
6.11 Lengthen
6.11.1 Lengthen Company Information
6.11.2 Lengthen Description and Business Overview
6.11.3 Lengthen Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lengthen Hemodialyzer and Hemoperfusion Product Portfolio
6.11.5 Lengthen Recent Developments/Updates
6.12 Shanghai Peony Medical
6.12.1 Shanghai Peony Medical Company Information
6.12.2 Shanghai Peony Medical Description and Business Overview
6.12.3 Shanghai Peony Medical Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai Peony Medical Hemodialyzer and Hemoperfusion Product Portfolio
6.12.5 Shanghai Peony Medical Recent Developments/Updates
6.13 Chengdu OCI Medical
6.13.1 Chengdu OCI Medical Company Information
6.13.2 Chengdu OCI Medical Description and Business Overview
6.13.3 Chengdu OCI Medical Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Chengdu OCI Medical Hemodialyzer and Hemoperfusion Product Portfolio
6.13.5 Chengdu OCI Medical Recent Developments/Updates
6.14 Bain Medical Equipment
6.14.1 Bain Medical Equipment Company Information
6.14.2 Bain Medical Equipment Description and Business Overview
6.14.3 Bain Medical Equipment Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bain Medical Equipment Hemodialyzer and Hemoperfusion Product Portfolio
6.14.5 Bain Medical Equipment Recent Developments/Updates
6.15 Jafron Biomedical
6.15.1 Jafron Biomedical Company Information
6.15.2 Jafron Biomedical Description and Business Overview
6.15.3 Jafron Biomedical Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jafron Biomedical Hemodialyzer and Hemoperfusion Product Portfolio
6.15.5 Jafron Biomedical Recent Developments/Updates
6.16 Kaneka Medix Corporation
6.16.1 Kaneka Medix Corporation Company Information
6.16.2 Kaneka Medix Corporation Description and Business Overview
6.16.3 Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Product Portfolio
6.16.5 Kaneka Medix Corporation Recent Developments/Updates
6.17 CytoSorbents
6.17.1 CytoSorbents Company Information
6.17.2 CytoSorbents Description and Business Overview
6.17.3 CytoSorbents Hemodialyzer and Hemoperfusion Sales, Revenue and Gross Margin (2020-2025)
6.17.4 CytoSorbents Hemodialyzer and Hemoperfusion Product Portfolio
6.17.5 CytoSorbents Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemodialyzer and Hemoperfusion Industry Chain Analysis
7.2 Hemodialyzer and Hemoperfusion Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemodialyzer and Hemoperfusion Production Mode & Process Analysis
7.4 Hemodialyzer and Hemoperfusion Sales and Marketing
7.4.1 Hemodialyzer and Hemoperfusion Sales Channels
7.4.2 Hemodialyzer and Hemoperfusion Distributors
7.5 Hemodialyzer and Hemoperfusion Customer Analysis
8 Hemodialyzer and Hemoperfusion Market Dynamics
8.1 Hemodialyzer and Hemoperfusion Industry Trends
8.2 Hemodialyzer and Hemoperfusion Market Drivers
8.3 Hemodialyzer and Hemoperfusion Market Challenges
8.4 Hemodialyzer and Hemoperfusion Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hemodialyzer and Hemoperfusion Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hemodialyzer and Hemoperfusion Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hemodialyzer and Hemoperfusion Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hemodialyzer and Hemoperfusion Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hemodialyzer and Hemoperfusion Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hemodialyzer and Hemoperfusion Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hemodialyzer and Hemoperfusion Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hemodialyzer and Hemoperfusion Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hemodialyzer and Hemoperfusion, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hemodialyzer and Hemoperfusion, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hemodialyzer and Hemoperfusion, Product Type & Application
 Table 12. Global Key Manufacturers of Hemodialyzer and Hemoperfusion, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hemodialyzer and Hemoperfusion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemodialyzer and Hemoperfusion as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hemodialyzer and Hemoperfusion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hemodialyzer and Hemoperfusion Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hemodialyzer and Hemoperfusion Sales Market Share by Region (2020-2025)
 Table 19. Global Hemodialyzer and Hemoperfusion Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hemodialyzer and Hemoperfusion Sales Market Share by Region (2026-2031)
 Table 21. Global Hemodialyzer and Hemoperfusion Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hemodialyzer and Hemoperfusion Revenue Market Share by Region (2020-2025)
 Table 23. Global Hemodialyzer and Hemoperfusion Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hemodialyzer and Hemoperfusion Revenue Market Share by Region (2026-2031)
 Table 25. North America Hemodialyzer and Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hemodialyzer and Hemoperfusion Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hemodialyzer and Hemoperfusion Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hemodialyzer and Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hemodialyzer and Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hemodialyzer and Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hemodialyzer and Hemoperfusion Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hemodialyzer and Hemoperfusion Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hemodialyzer and Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hemodialyzer and Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hemodialyzer and Hemoperfusion Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hemodialyzer and Hemoperfusion Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hemodialyzer and Hemoperfusion Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hemodialyzer and Hemoperfusion Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hemodialyzer and Hemoperfusion Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hemodialyzer and Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hemodialyzer and Hemoperfusion Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hemodialyzer and Hemoperfusion Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hemodialyzer and Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hemodialyzer and Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hemodialyzer and Hemoperfusion Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hemodialyzer and Hemoperfusion Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hemodialyzer and Hemoperfusion Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hemodialyzer and Hemoperfusion Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hemodialyzer and Hemoperfusion Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hemodialyzer and Hemoperfusion Sales (K Units) by Type (2020-2025)
 Table 51. Global Hemodialyzer and Hemoperfusion Sales (K Units) by Type (2026-2031)
 Table 52. Global Hemodialyzer and Hemoperfusion Sales Market Share by Type (2020-2025)
 Table 53. Global Hemodialyzer and Hemoperfusion Sales Market Share by Type (2026-2031)
 Table 54. Global Hemodialyzer and Hemoperfusion Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hemodialyzer and Hemoperfusion Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hemodialyzer and Hemoperfusion Revenue Market Share by Type (2020-2025)
 Table 57. Global Hemodialyzer and Hemoperfusion Revenue Market Share by Type (2026-2031)
 Table 58. Global Hemodialyzer and Hemoperfusion Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hemodialyzer and Hemoperfusion Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hemodialyzer and Hemoperfusion Sales (K Units) by Application (2020-2025)
 Table 61. Global Hemodialyzer and Hemoperfusion Sales (K Units) by Application (2026-2031)
 Table 62. Global Hemodialyzer and Hemoperfusion Sales Market Share by Application (2020-2025)
 Table 63. Global Hemodialyzer and Hemoperfusion Sales Market Share by Application (2026-2031)
 Table 64. Global Hemodialyzer and Hemoperfusion Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hemodialyzer and Hemoperfusion Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hemodialyzer and Hemoperfusion Revenue Market Share by Application (2020-2025)
 Table 67. Global Hemodialyzer and Hemoperfusion Revenue Market Share by Application (2026-2031)
 Table 68. Global Hemodialyzer and Hemoperfusion Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hemodialyzer and Hemoperfusion Price (US$/Unit) by Application (2026-2031)
 Table 70. Fresenius Medical Care Company Information
 Table 71. Fresenius Medical Care Description and Business Overview
 Table 72. Fresenius Medical Care Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Fresenius Medical Care Hemodialyzer and Hemoperfusion Product
 Table 74. Fresenius Medical Care Recent Developments/Updates
 Table 75. Baxter Company Information
 Table 76. Baxter Description and Business Overview
 Table 77. Baxter Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Baxter Hemodialyzer and Hemoperfusion Product
 Table 79. Baxter Recent Developments/Updates
 Table 80. Nipro Company Information
 Table 81. Nipro Description and Business Overview
 Table 82. Nipro Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Nipro Hemodialyzer and Hemoperfusion Product
 Table 84. Nipro Recent Developments/Updates
 Table 85. Asahi Kasei Company Information
 Table 86. Asahi Kasei Description and Business Overview
 Table 87. Asahi Kasei Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Asahi Kasei Hemodialyzer and Hemoperfusion Product
 Table 89. Asahi Kasei Recent Developments/Updates
 Table 90. Toray Company Information
 Table 91. Toray Description and Business Overview
 Table 92. Toray Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Toray Hemodialyzer and Hemoperfusion Product
 Table 94. Toray Recent Developments/Updates
 Table 95. B.Braun Company Information
 Table 96. B.Braun Description and Business Overview
 Table 97. B.Braun Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. B.Braun Hemodialyzer and Hemoperfusion Product
 Table 99. B.Braun Recent Developments/Updates
 Table 100. Nikkiso Company Information
 Table 101. Nikkiso Description and Business Overview
 Table 102. Nikkiso Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Nikkiso Hemodialyzer and Hemoperfusion Product
 Table 104. Nikkiso Recent Developments/Updates
 Table 105. SB-KAWASUM Company Information
 Table 106. SB-KAWASUM Description and Business Overview
 Table 107. SB-KAWASUM Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. SB-KAWASUM Hemodialyzer and Hemoperfusion Product
 Table 109. SB-KAWASUM Recent Developments/Updates
 Table 110. Medica Group Company Information
 Table 111. Medica Group Description and Business Overview
 Table 112. Medica Group Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Medica Group Hemodialyzer and Hemoperfusion Product
 Table 114. Medica Group Recent Developments/Updates
 Table 115. WEGO Group Company Information
 Table 116. WEGO Group Description and Business Overview
 Table 117. WEGO Group Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. WEGO Group Hemodialyzer and Hemoperfusion Product
 Table 119. WEGO Group Recent Developments/Updates
 Table 120. Lengthen Company Information
 Table 121. Lengthen Description and Business Overview
 Table 122. Lengthen Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Lengthen Hemodialyzer and Hemoperfusion Product
 Table 124. Lengthen Recent Developments/Updates
 Table 125. Shanghai Peony Medical Company Information
 Table 126. Shanghai Peony Medical Description and Business Overview
 Table 127. Shanghai Peony Medical Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Shanghai Peony Medical Hemodialyzer and Hemoperfusion Product
 Table 129. Shanghai Peony Medical Recent Developments/Updates
 Table 130. Chengdu OCI Medical Company Information
 Table 131. Chengdu OCI Medical Description and Business Overview
 Table 132. Chengdu OCI Medical Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Chengdu OCI Medical Hemodialyzer and Hemoperfusion Product
 Table 134. Chengdu OCI Medical Recent Developments/Updates
 Table 135. Bain Medical Equipment Company Information
 Table 136. Bain Medical Equipment Description and Business Overview
 Table 137. Bain Medical Equipment Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Bain Medical Equipment Hemodialyzer and Hemoperfusion Product
 Table 139. Bain Medical Equipment Recent Developments/Updates
 Table 140. Jafron Biomedical Company Information
 Table 141. Jafron Biomedical Description and Business Overview
 Table 142. Jafron Biomedical Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Jafron Biomedical Hemodialyzer and Hemoperfusion Product
 Table 144. Jafron Biomedical Recent Developments/Updates
 Table 145. Kaneka Medix Corporation Company Information
 Table 146. Kaneka Medix Corporation Description and Business Overview
 Table 147. Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Kaneka Medix Corporation Hemodialyzer and Hemoperfusion Product
 Table 149. Kaneka Medix Corporation Recent Developments/Updates
 Table 150. CytoSorbents Company Information
 Table 151. CytoSorbents Description and Business Overview
 Table 152. CytoSorbents Hemodialyzer and Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. CytoSorbents Hemodialyzer and Hemoperfusion Product
 Table 154. CytoSorbents Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Hemodialyzer and Hemoperfusion Distributors List
 Table 158. Hemodialyzer and Hemoperfusion Customers List
 Table 159. Hemodialyzer and Hemoperfusion Market Trends
 Table 160. Hemodialyzer and Hemoperfusion Market Drivers
 Table 161. Hemodialyzer and Hemoperfusion Market Challenges
 Table 162. Hemodialyzer and Hemoperfusion Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hemodialyzer and Hemoperfusion
 Figure 2. Global Hemodialyzer and Hemoperfusion Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hemodialyzer and Hemoperfusion Market Share by Type: 2024 & 2031
 Figure 4. Hemodialyzer Product Picture
 Figure 5. Hemoperfusion Product Picture
 Figure 6. Global Hemodialyzer and Hemoperfusion Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hemodialyzer and Hemoperfusion Market Share by Application: 2024 & 2031
 Figure 8. Dialysis Centers
 Figure 9. Hospitals
 Figure 10. Other
 Figure 11. Global Hemodialyzer and Hemoperfusion Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Hemodialyzer and Hemoperfusion Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Hemodialyzer and Hemoperfusion Sales (2020-2031) & (K Units)
 Figure 14. Global Hemodialyzer and Hemoperfusion Average Price (US$/Unit) & (2020-2031)
 Figure 15. Hemodialyzer and Hemoperfusion Report Years Considered
 Figure 16. Hemodialyzer and Hemoperfusion Sales Share by Manufacturers in 2024
 Figure 17. Global Hemodialyzer and Hemoperfusion Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Hemodialyzer and Hemoperfusion Players: Market Share by Revenue in Hemodialyzer and Hemoperfusion in 2024
 Figure 19. Hemodialyzer and Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Hemodialyzer and Hemoperfusion Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Hemodialyzer and Hemoperfusion Sales Market Share by Country (2020-2031)
 Figure 22. North America Hemodialyzer and Hemoperfusion Revenue Market Share by Country (2020-2031)
 Figure 23. United States Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Hemodialyzer and Hemoperfusion Sales Market Share by Country (2020-2031)
 Figure 26. Europe Hemodialyzer and Hemoperfusion Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Hemodialyzer and Hemoperfusion Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Hemodialyzer and Hemoperfusion Revenue Market Share by Region (2020-2031)
 Figure 34. China Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Hemodialyzer and Hemoperfusion Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Hemodialyzer and Hemoperfusion Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Hemodialyzer and Hemoperfusion Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Hemodialyzer and Hemoperfusion Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Hemodialyzer and Hemoperfusion Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Hemodialyzer and Hemoperfusion by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Hemodialyzer and Hemoperfusion by Type (2020-2031)
 Figure 53. Global Hemodialyzer and Hemoperfusion Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Hemodialyzer and Hemoperfusion by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Hemodialyzer and Hemoperfusion by Application (2020-2031)
 Figure 56. Global Hemodialyzer and Hemoperfusion Price (US$/Unit) by Application (2020-2031)
 Figure 57. Hemodialyzer and Hemoperfusion Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart